Multi-centre Clinical Trial on Hormone Replacement Treatment in China
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Menopausal Syndrome|Cardiovascular Disease|Osteoporosis|Breast Cancer
Interventions: DRUG: estradiol plus MPA|DRUG: Ximingting Tablet|DRUG: estradiol plus progesterone
Sponsor: Peking Union Medical College Hospital